Association of Comorbidities With Overall Survival in Myelodysplastic Syndrome: Development of a Prognostic Model

Abstract

Comorbidities have a significant impact on the survival of patients with MDS. Patients with severe comorbidity had a 50% decrease in survival, independent of age and IPSS risk group. A comprehensive assessment of the severity of comorbidities helps predict survival in patients with MDS.